Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Cancer
|
July 28, 2007
Hypoxia upregulates carcinoembryonic antigen expression in cancer cells
Nina Kokkonen, Ines Fernandez Ulibarri, Annika Kauppila, et al.
Frontiers in Immunology
|
October 19, 2020
Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease
Antti Nätynki, Jussi Tuusa, Kaisa Hervonen, et al.
The Journal of Investigative Dermatology
|
August 3, 2022
Dipeptidyl Peptidase 4 Inhibitor‒Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin
Jussi Tuusa, Nina Kokkonen, Anja Mattila, et al.
The Journal of Investigative Dermatology
|
September 22, 2016
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease
Nina Kokkonen, Sanna-Kaisa Herukka, Laura Huilaja, et al.
The Journal of Investigative Dermatology
|
October 14, 2014
Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice
Tiina Hurskainen, Nina Kokkonen, Raija Sormunen, et al.
Acta Dermato-Venereologica
|
November 22, 2016
Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis
Minna E Kubin, Nina Kokkonen, Riitta Palatsi, et al.
European Journal of Dermatology : EJD
|
December 30, 2015
Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses
Minna E Kubin, Päivi M Hägg, Nina Kokkonen, et al.
Frontiers in Immunology
|
August 12, 2022
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
Antti Nätynki, Päivi Leisti, Jussi Tuusa, et al.
Acta Dermato-Venereologica
|
April 20, 2016
Expression of Glucocorticoid Receptors GRα and GRβ in Bullous Pemphigoid
Minna E Kubin, Päivi M Hägg, Nina Kokkonen, et al.
The Journal of Investigative Dermatology
|
October 14, 2018
BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid
Jussi Tuusa, Outi Lindgren, Hanna-Mari Tertsunen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Cancer
|
July 28, 2007
Hypoxia upregulates carcinoembryonic antigen expression in cancer cells
Nina Kokkonen, Ines Fernandez Ulibarri, Annika Kauppila, et al.
Frontiers in Immunology
|
October 19, 2020
Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease
Antti Nätynki, Jussi Tuusa, Kaisa Hervonen, et al.
The Journal of Investigative Dermatology
|
August 3, 2022
Dipeptidyl Peptidase 4 Inhibitor‒Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin
Jussi Tuusa, Nina Kokkonen, Anja Mattila, et al.
The Journal of Investigative Dermatology
|
September 22, 2016
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease
Nina Kokkonen, Sanna-Kaisa Herukka, Laura Huilaja, et al.
The Journal of Investigative Dermatology
|
October 14, 2014
Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice
Tiina Hurskainen, Nina Kokkonen, Raija Sormunen, et al.
Acta Dermato-Venereologica
|
November 22, 2016
Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis
Minna E Kubin, Nina Kokkonen, Riitta Palatsi, et al.
European Journal of Dermatology : EJD
|
December 30, 2015
Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses
Minna E Kubin, Päivi M Hägg, Nina Kokkonen, et al.
Frontiers in Immunology
|
August 12, 2022
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
Antti Nätynki, Päivi Leisti, Jussi Tuusa, et al.
Acta Dermato-Venereologica
|
April 20, 2016
Expression of Glucocorticoid Receptors GRα and GRβ in Bullous Pemphigoid
Minna E Kubin, Päivi M Hägg, Nina Kokkonen, et al.
The Journal of Investigative Dermatology
|
October 14, 2018
BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid
Jussi Tuusa, Outi Lindgren, Hanna-Mari Tertsunen, et al.
Page
of 3